Therapy of 'high risk' myelodysplastic syndromes with an association of low-dose Ara-C, retinoic acid and 1, 25-dihydroxyvitamin D3

Biomedicine and Pharmacotherapy

Volumn 46, Issue 5-7, 1992, Pages 211-217

  De Rosa, L ^a   Montuoro, A ^a   De Laurenzi, A ^a  

^a SAN CAMILLO FORLANINI HOSPITAL   (Italy)

Author keywords

acide r tfno que; cytosine arabinoside; myelodysplastic syndromes; retinoic acid; syndromes my lodysplastiques; vitamin D3; vitamine D3

Indexed keywords

CALCITRIOL; CYTARABINE; RETINOIC ACID;

ADULT; AGED; APLASTIC ANEMIA; BLAST CELL; BLOOD CELL; BONE MARROW CELL; BONE MARROW SUPPRESSION; CELL TRANSFORMATION; CHRONIC MYELOMONOCYTIC LEUKEMIA; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; HIGH RISK PATIENT; HUMAN; MALE; MYELODYSPLASTIC SYNDROME; STOMATITIS; SURVIVAL;

AGED; AGED, 80 AND OVER; CALCITRIOL; CYTARABINE; DRUG THERAPY, COMBINATION; FEMALE; HUMAN; MALE; MIDDLE AGE; MYELODYSPLASTIC SYNDROMES; PROSPECTIVE STUDIES; RISK FACTORS; TRETINOIN;

EID: 0026731328     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/0753-3322(92)90084-K     Document Type: Article

References (28)

1. Treatment of advanced myelodysplastic syndromes with recombinant interferon-alpha2b
2. Proposals for the classification of the myelodysplastic syndromes
3. A critical appraisal of low-dose cytosine arabinoside in patients with acute non-lymphocytic leukemia and myelodysplastic syndromes
4. The myelodysplastic syndromes: current approaches to therapy
5. A randomized trial of 13-cis retinoic acid with or without cytosine arabinoside in patients with the myelodysplastic syndrome
6. Dysmyelopoietic syndromes: a search for prognostic factors in 193 patients
7. Prognostic factors in myelodysplastic syndromes with excess of blasts. A multivariate analysis
8. Myelodysplastic syndromes: a clinical and pathological analysis of 109 cases
9. Synergistic interaction between differentiation inducers and DNA synthesis inhibitors: a new approach to differentiation induction in myelodysplasia and acute myeloid leukemia
10. Phase I clinical trial of 13-cis-retinoic acid in myelodysplastic syndromes
11. Therapeutic effects of low-dose cytosine arabinoside, alpha-interferon, 1-alfa-hydroxyvitamin D3 and retinoic acid in acute leukemia and myelodysplastic syndromes
12. Treatment of myelodysplastic syndromes with retinoic acid and alfa-hydroxy-vitamin D3 in combination with low-dose ara-C is not superior to ara-C alone. Results from a randomized study
13. Combination of low-dose cytarabine and 13-cis retinoic acid in the treatment of myelodysplastic syndromes
14. An International system for human cytogenetic nomenclature
15. Non-parametric estimation from incomplete observations
16. 1, 25-dihydroxy-vitamin D3: In vitro and in vivo effects on human preleukemic and leukemic cells
17. Randomized study of 13-cis retinoic acid vs placebo in the myelodysplastic syndromes
18. Potential pre-screening for therapeutic agents that induce differentiation in human myeloid leukemia cells
19. Reporting results of cancer treatment
20. Evaluation of low dose ara-C versus supportive care in the treatment of myelodysplastic syndromes: An intergroup study by the Eastern Cooperative Oncology Group and the Southwest Oncology Group
21. Myelodysplastic syndromes: a scoring system with prognostic significance
22. Design and analysis of randomised clinical trials requiring prolonged observations of each patient: Part 2. Analysis and examples
23. Treatment of myelodysplastic syndrome with 1,25 dihydroxy-vitamin D3
24. The differentiation of myeloid leukemia cells. New possibilities for therapy
25. Responses of hemopoietic precursors to 13-cis retinoic acid and 1,25 dihydroxy-vitamin D3 in the myelodysplastic syndromes
26. Prognostic factors in the myelodysplastic syndromes: importance of initial data on peripheral blood counts, bone marrow cytology, trephine biopsy and chromosomal analysis
27. Management of the myelodys-plastic syndromes
28. Chronic myelodysplastic syndrome: short survival with or without evolution to acute leukemia